NeoProteomics

NeoProteomics is a private contract research and proteomics services company focused on structural mass spectrometry and protein characterization for pharmaceutical, biotechnology, and academic customers. The company provides protein footprinting, protein-drug interaction mapping, epitope mapping, and related structural biology services used to analyze therapeutic proteins and biologics. Founded in 2006 in the Cleveland, Ohio area, NeoProteomics was established by Dr. Mark Chance and co-founders with roots in Case Western Reserve University. Its business appears to center on fee-for-service research, proprietary analytical methods, and consulting rather than development of an in-house therapeutic pipeline. The company serves clients worldwide and is positioned as a specialized life sciences tools and services provider for biologic drug discovery and characterization.